Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological standardization of allergen extracts (Phleum pratense, Olea europaea, Dermatophagoides pteronyssinus, Felis domesticus)
2012-005362-35Phase 2Completed
- Sponsor
- Inmunal
- Start
- Feb 2013
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of dermatophagoides pteronyssinus extract, allergovac depot, olea europaea pollen extract, Felis Catus in allergic rhinitis (AR), allergic asthma, allergic conjunctivitis (AC), sponsored by Inmunal. Started Feb 2013; status: completed.
02
Drugs
dermatophagoides pteronyssinus extractallergovac depotolea europaea pollen extractFelis Catus
03
Conditions
allergic rhinitis (AR)allergic asthmaallergic conjunctivitis (AC)
Beyond the preview
Go deeper on 2012-005362-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005362-35.